PFNLive
Royalty Pharma Meeting With Elan Investors on Bid
Published: Wednesday, March 6th 2013
(Bloomberg) - Royalty Pharma said it’s meeting with “a number of” Elan Corp. (ELN) shareholders to persuade them to accept Royalty’s offer to buy the Irish drugmaker.
The company “remains committed to acquiring Elan on the terms set out” in its Feb. 25 offer, New York-based Royalty said today in a statement.
Read more.
Comment(s)
Your comments are valuable to us. Thank you.
